International Clinical Trials Day (ICTD) 2016

Clinical trials in the era of personalised medicine

ICTD 2016 Prague Together with the Czech scientific partner CZECRIN, ECRIN organised ICTD 2016 on May 20 2016 in the Senate of the Parliament in Prague, Czech Republic. ICTD 2016 aimed to increase awareness of ECRIN and its Czech national scientific partner among Czech policymakers and the scientific community, as well as to address issues related to personalised medicine and multinational clinical trials.

Discover the ICTD 2016 agenda and photos below.

ICTD 2016 Speakers topics

Jan Zaloudik Chairman of the Committee on Health and Social Policy (Czech Republic)	Opening & Introduction ICTD 2017
Robert Plaga Deputy Minister, Ministry of Education, Youth and Sports (Czech Republic)	Research infrastructures in the Czech Republic
Radek Policar Deputy Minister, Ministry of Health (Czech Republic)	Clinical trials as a part of clinical research in the Czech Republic
Jacques Demotes Director General, ECRIN	Introduction to ECRIN, the instrument for multinational trials in Europe
Regina Demlová CZECRIN Scientific Partner and Head of Pharmacology, Masaryk University (Czech Republic)	CZECRIN, the Czech national partner of ECRIN
Dalibor Valík Head of the Department of Laboratory Medicine and Managing Director of the Regional Centre for Applied Medical Oncology (RECAMO), Masaryk Memorial Cancer Institute (Czech Republic)	Clinical component of ESFRI infrastructures - current issues and future challenges
Jakub Dvořáček CEO of Association of Innovative Pharmaceutical Industry (AIFP) (Czech Republic)	Clinical trials in the Czech Republic from an industry perspective
Silvio Garattini Director, Istituto di Ricerche Farmacologiche Mario Negri (IRCCS) (Italy) Christian Gluud Head of Department, Copenhagen Trial Unit, Centre for Clinical Intervention Research (Denmark)	Personalised medicine - definition, case study
Anna Pokorska-Bocci Senior Scientific Officer, Personalised Medicine, Debiopharm International SA (United Kingdom)	What is personalised medicine? Use and meaning of the term
Dhavendra Kumar Consultant in Clinical Genetics, Institute of Cancer & Genetics, Cardiff University School of Medicine (United Kingdom)	Personalised medicine and evidence based medicine
Norbert Graf Professor of Paediatrics and Head of Paediatric Oncology, Saarland University (Germany)	Development of personalised medicine within child oncology - a case study
Ian Roberts Professor of Epidemiology and Public Health and Co-director of the Clinical Trials Unit at the London School of Hygiene & Tropical Medicine (LSHTM) (United Kingdom)	Methodological aspects and challenges of personalised medicine
Nicole Nelson Assistant Professor, Department of History of Science, University of Wisconsin – Madison (United States)	Ethical aspects of personalised medicine
Marisa Papaluca Senior Scientific Advisor, European Medicines Agency (EMA) (United Kingdom)	Regulatory challenges and views on personalised medicine
Gonzalo Calvo Senior Consultant at Hospital Clinic Barcelona and Associate Professor of Clinical Pharmacology, University of Barcelona (Spain) Christian Gluud Head of Department, Copenhagen Trial Unit, Centre for Clinical Intervention Research (Denmark)	Personalised medicine - scientific, industry and patient perspectives
Paraskevi Katsaounou Assistant Professor of Pulmonary Medicine, University of Athens Medical School, Evaggelismos Hospital (Greece)	Personalised medicine from a scientific perspective
Denis Horgan Executive Director, European Alliance for Personalised Medicine (Belgium)	Personalised medicine from a multi-stakeholder perspective
Magda Chlebus Director of Science Policy at the European Federation of Pharmaceutical Industries and Associations (EFPIA) (Belgium)	Personalised medicine from an industry perspective
All chairs and speakers	What is the future of clinical trials and evidence based medicine in the era of personalised medicine?
Jacques Demotes Director General, ECRIN	Conclusion

#Communications & Outreach #Event #International Clinical Trial Day #Personalised Medicine